Study of regulatory requirements for the conduct of bioequivalence studies in US, Europe, Canada, India, ASEAN and SADC countries: Impact on generic drug substitution.
Article
de En
| IMSEAR
| ID: sea-176988
Texte intégral:
1
Indice:
IMSEAR
langue:
En
Année:
2016
Type:
Article